Drug · DIN 02564041
PLOSBRIO
DISPENSES 0.25 MG OR 0.5 MG DOSES. MULTIDOSE PREFILLED PEN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since December 22, 2025.
- Drug Identification Number (DIN)
- 02564041
- Company (DIN owner)
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Semaglutide A10BJ06
- Class
- Human
- Record last updated
- September 4, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SEMAGLUTIDE | 0.68 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- December 22, 2025: NOC 36610New Drug Submission (NDS) · Administrative – Additional product name
Other DINs named PLOSBRIO
- DIN 02564068 · Approved
- DIN 02564076 · Approved
- DIN 02564084 · Approved
- DIN 02568233 · Approved
- DIN 02568241 · Approved